E3 Metals Receives Federal Government Grant for Expanded Lithium Extraction Technology Research with the University of Alberta
Ascendant Resources Almost Triples Contained Zinc in Mineral Reserves at El Mochito Extending Life of Mine Beyond 7 Years
Zynerba Pharmaceuticals Initiates Open-Label Phase 2 Trial of ZYN002 in Developmental and Epileptic Encephalopathies
Wave Life Sciences and Deep Genomics Form Collaboration to Discover Novel Therapies for Genetic Neuromuscular Disorders
Neuralstem Announces First Surgery Completed in Cervical Cohort of Phase 1 Clinical Trial in Patients with Chronic Spinal Cord Injury
BeiGene Initiates Global Phase 2 Trial of Anti-PD-1 Antibody Tislelizumab in Patients with Previously Treated Hepatocellular Carcinoma
Loxo Oncology and Illumina to Partner on Developing Next-Generation Sequencing-Based Pan-Cancer Companion Diagnostics
Medtronic Expands Visualase(TM) MRI-Guided Laser Ablation System to European Markets with CE Mark Approval
AGTC Announces Completion of Enrollment of Phase 1 / 2 Clinical Study of Investigational Gene Therapy
Gold Resource Corporation Extends Arista Vein System High-Grade With Intercepts Including 2 Meters of 6.68 g/t Gold and 864 g/t Silver
Enterprise Group Deploys Proprietary Asset Tracking & Dispatch Software “Star” to Lower Costs and Increase Margins
dynaCERT Expands its Dealer Network in the Middle East with Mr. Maheboob Nagji and Closes Second Tranche of Equity Private Placement
Brixton Metals Drills 5.00m of 0.23% Cobalt, 2.10% Copper, 94.96 g/t Silver Including 2.00m of 0.72% Cobalt Equivalent
Alexco Environmental Group and Colorado Legacy Land LLC Partner to Cleanup Legacy Uranium Mining and Processing Sites in Central Colorado
Canada Carbon Receives First Two Favorable Court Decisions Against the Municipality of Grenville-sur-la-Rouge
Zinc One Drill Program at Bongará Mine Project, Peru Confirms New High-Grade Zinc Mineralization in Mina Chica Zone
EyeGate Receives FDA Feedback on Investigational Device Exemption Amendment for Second Pilot Study of Ocular Bandage Gel
Minerva Neurosciences Screens First Patient in Phase 2b Trial of MIN-117 to Treat Major Depressive Disorder
Data Monitoring Committee Completes Planned Safety and Data Review of Celsion’s Phase III OPTIMA Study
Menlo Therapeutics Announces Results from a Phase 2 Trial of Serlopitant for Pruritus Associated with Atopic Dermatitis
Inspire Medical Systems Announces Filing of Registration Statement for Proposed Initial Public Offering